Physician profile
Ilya Reyter
NPI 1558456517
$4,847.86
in general payments reported to CMS, 2019-2025
25 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $165 · 2021: $478 · 2022: $612 · 2023: $1,185 · 2024: $929 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,592.61 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $891.07 | 2019-2025 | |
| Genzyme Corporation | $799.60 | 2022-2025 | |
| Galderma Laboratories, L.P. | $590.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $564.36 | 2019-2025 | |
| Biofrontera INC. | $304.42 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Incyte Corporation | $295.74 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $270.83 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $248.86 | 2019-2025 | Dupixent |
| Allergan, INC. | $212.80 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $173.52 | 2019-2025 | |
| Ucb, INC. | $107.48 | 2023 | Cimzia, Bimzelx |
| Dermavant Sciences, INC. | $69.87 | 2023-2024 | Vtama |
| Almirall LLC | $54.94 | 2019-2023 | Klisyri |
| Dusa Pharmaceuticals, INC. | $50.92 | 2019 | |
| Epi Health, LLC | $27.37 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $25.82 | 2019 | |
| Amgen INC. | $22.98 | 2021 | |
| Lilly USA, LLC | $21.54 | 2024 | Taltz, Zepbound |
| Celgene Corporation | $18.76 | 2019 | |
| Mayne Pharma Commercial LLC | $18.46 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.34 | 2025 | Cabtreo |
| Arcutis Biotherapeutics, INC. | $16.09 | 2024 | Zoryve |
| Strata Skin Sciences, INC. | $15.95 | 2022 | |
| Tactile Systems Technology INC | $14.39 | 2020 | |
| Pfizer INC. | $13.34 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Reyter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.